Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jeffrey

Showing results (21-30 of 757) with videos related to

Pageof 76
Sort By:
The Clinical Biochemist. Reviews|May 7, 2008
Clinical penetrance of C282Y homozygous HFE haemochromatosisEnrico Rossi, Gary P Jeffrey
Future Neurology|April 1, 2015
The hippocampo-prefrontal pathway: a possible therapeutic target for negative and cognitive symptoms of schizophreniaAyan Ghoshal, P Jeffrey Conn
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 31, 2007
Challenges for blood-brain barrier (BBB) screeningP Jeffrey, S G Summerfield
American Journal of Hospital Pharmacy|January 1, 1980
Pharmacy service units: the evolution of a conceptL P Jeffrey, J N Gallina
Current Opinion in Pharmacology|December 3, 2014
Group I and group II metabotropic glutamate receptor allosteric modulators as novel potential antipsychoticsAdam G Walker, P Jeffrey Conn
Hospital Pharmacy|December 12, 1983
Involving your staff in committees and meetingsC D Mahoney, L P Jeffrey
Anatomy and Embryology|April 1, 1997
Actin and tropomyosin isoforms in morphogenesisP Gunning, R Weinberger, P Jeffrey
Pediatrics|December 29, 1998
Phenytoin dosageJ Sharfstein, D Agrawal, P Jeffrey
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 17, 2008
Promise of mGluR2/3 activators in psychiatryP Jeffrey Conn, Carrie K Jones
Molecular Pharmacology|March 27, 2015
Molecular Insights into Metabotropic Glutamate Receptor Allosteric ModulationKaren J Gregory, P Jeffrey Conn
Pageof 76

Showing results (21-30 of 757) with videos related to

Sort By:
Pageof 76
The Clinical Biochemist. Reviews|May 7, 2008
Clinical penetrance of C282Y homozygous HFE haemochromatosisEnrico Rossi, Gary P Jeffrey
Future Neurology|April 1, 2015
The hippocampo-prefrontal pathway: a possible therapeutic target for negative and cognitive symptoms of schizophreniaAyan Ghoshal, P Jeffrey Conn
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 31, 2007
Challenges for blood-brain barrier (BBB) screeningP Jeffrey, S G Summerfield
American Journal of Hospital Pharmacy|January 1, 1980
Pharmacy service units: the evolution of a conceptL P Jeffrey, J N Gallina
Current Opinion in Pharmacology|December 3, 2014
Group I and group II metabotropic glutamate receptor allosteric modulators as novel potential antipsychoticsAdam G Walker, P Jeffrey Conn
Hospital Pharmacy|December 12, 1983
Involving your staff in committees and meetingsC D Mahoney, L P Jeffrey
Anatomy and Embryology|April 1, 1997
Actin and tropomyosin isoforms in morphogenesisP Gunning, R Weinberger, P Jeffrey
Pediatrics|December 29, 1998
Phenytoin dosageJ Sharfstein, D Agrawal, P Jeffrey
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 17, 2008
Promise of mGluR2/3 activators in psychiatryP Jeffrey Conn, Carrie K Jones
Molecular Pharmacology|March 27, 2015
Molecular Insights into Metabotropic Glutamate Receptor Allosteric ModulationKaren J Gregory, P Jeffrey Conn
Pageof 76